Stay updated with breaking news from Lpcn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note issued to investors on Tuesday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Up 1.6 % LPCN opened at $5.21 on Tuesday. The stock’s fifty day simple moving average is $4.92 and its 200 […]
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a report published on Monday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of NASDAQ LPCN opened at $3.67 on Monday. Lipocine has a fifty-two week low of $3.30 and a fifty-two week high of […]
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note published on Sunday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of LPCN stock opened at $0.27 on Friday. Lipocine has a 12-month low of $0.23 and a 12-month high of […]
StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a report released on Saturday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Up 4.0 % NASDAQ LPCN opened at $0.27 on Friday. The stock has a market capitalization of $23.93 million, a PE ratio of -1.93 […]
Lipocine Inc. (NASDAQ:LPCN – Get Rating) was the recipient of a significant drop in short interest in the month of March. As of March 31st, there was short interest totalling 1,160,000 shares, a drop of 7.9% from the March 15th total of 1,260,000 shares. Currently, 1.4% of the company’s stock are short sold. Based on […]